RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 Edoxaban Noninferior to Warfarin in Recurrent VTE and PE
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 15
SP 11
OP 12
DO 10.1177/155989771315005
UL http://mdc.sagepub.com/content/13/15/11.2.abstract
AB Edoxaban was noninferior to warfarin for prevention of recurrent venous thromboembolism (VTE) in patients with acute VTE who were initially treated with heparin. This article presents data from the Comparative Investigation of Edoxaban Tosylate (DU176b) Versus Warfarin in the Treatment of Symptomatic Deep-Vein Clots and/or Lung Blood Clots trial [Edoxaban Hokusai-VTE Study; Büller HR et al. N Engl J Med 2013].